EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis

Burcu Aydemir iD, Andrew C Heisler iD, Lutfiyya N Muhammad, Jing Song iD, Alyssa Wohlfahrt iD, Daniel J Clauw iD, Wendy Marder, Marcy B Bolster iD, Clifton O Bingham iD, Tuhina Neogi iD, Yvonne C Lee iD

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.43265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Burcu Aydemir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Chicago, Illinois. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Pain Threshold. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Abnormalities in pain regulatory mechanisms are common in patients with rheumatoid arthritis (RA). We investigated whether pain sensitization changes after treatment with a disease‐modifying antirheumatic drug (DMARD) and explored associations between changes in pain sensitization and disease activity.

Methods

We included 182 participants with active RA initiating/switching DMARD therapy who were observed for 12 weeks. To assess pain sensitization, participants underwent quantitative sensory testing (QST), including pressure pain thresholds (PPTs) at multiple anatomic sites, temporal summation (TS) at the wrist and forearm, and conditioned pain modulation (CPM). RA disease activity was measured using the Disease Activity Score 28 with C‐reactive protein (DAS28‐CRP) and its components. Mean changes in QST measures were examined from baseline to 12 weeks, and associations between QST and disease activity measures were explored using Pearson correlation coefficients and adjusted linear regression analyses.

Results

PPTs significantly increased (improved) at multiple anatomic sites following 12 weeks of DMARD therapy. No significant changes were observed in TS or CPM. Increased PPTs at multiple anatomic sites were associated with reductions in DAS28‐CRP, swollen joint count, tender joint count, and improvements in patient global assessment. No significant associations were observed between TS, CPM, and disease activity.

Conclusion

Pain sensitivity improved after 12 weeks of DMARD therapy. These improvements were associated with reductions in disease activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsPain ThresholdHumansMaleFemaleMiddle AgedAgedSeverity of Illness IndexPain MeasurementAdultC-Reactive Protein

Substanzen

Antirheumatic AgentsC-Reactive Protein

Autor:innen und Institutionen

  • Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Western Michigan University School of Medicine, Kalamazoo.
  • Massachusetts General Brigham, Boston.
  • University of Michigan Medical School, Ann Arbor.
  • Massachusetts General Hospital, Boston.
  • Johns Hopkins University School of Medicine, Baltimore, Maryland.

ORCID-Profile: Burcu Aydemir, Andrew C Heisler, Jing Song, Alyssa Wohlfahrt, Daniel J Clauw, Marcy B Bolster, Clifton O Bingham, Tuhina Neogi, Yvonne C Lee

Förderung

  • NIAMS NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Aydemir, B., Heisler, A. C., Muhammad, L. N., Song, J., Wohlfahrt, A., Clauw, D. J., Marder, W., Bolster, M. B., Bingham, C. O., Neogi, T., & Lee, Y. C. (2025). Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43265

Vancouver

Aydemir B, Heisler AC, Muhammad LN, Song J, Wohlfahrt A, Clauw DJ, et al. Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis. Arthritis & Rheumatology. 2025. doi:10.1002/art.43265

BibTeX
@article{Aydemir2025,
  author = {Aydemir, Burcu and Heisler, Andrew C and Muhammad, Lutfiyya N and Song, Jing and Wohlfahrt, Alyssa and Clauw, Daniel J and Marder, Wendy and Bolster, Marcy B and Bingham, Clifton O and Neogi, Tuhina and Lee, Yvonne C},
  title = {Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.43265}
}
Kostenlos starten →